NAD+ (Buffered) 1000 mg
What is on file for this vial.
Brand
Maker not published for this row — sold in the supplier's own packaging.
Lab reports
No third-party COA held for this row — verification pending, nothing implied.
Questions about this vial.
What is in one unit?
One unit is COMBO, as stated upstream. The price on this page is quoted for that unit.
Who wrote the description above?
The supplier, and what they publish for this vial is unusually short. We print what they wrote rather than filling the gap ourselves; the specification and the paperwork below are the parts we can stand behind.
Is there a lab report for this vial?
No third-party lab report is published for this line, so this page carries none — we would rather leave the section empty than print a certification we cannot back. Where a report does exist, it is published on the product page it belongs to, under Batch documentation, with the lab, the batch, the measured values and the verification key you can check at the lab. For this line, send us your order number and the batch printed on your box and we request that batch's paperwork from the supplier.
How is it shipped, and how fast?
Payment clearing on a working day means same-day dispatch, and most parcels arrive in about 4 days, tracked, inside the European Union, in an unmarked box. One flat €20.00 per order. Nothing ships refrigerated — lyophilised peptide holds at room temperature in transit.
Can I return it?
Unopened, seal intact, within 14 days of delivery, at your postage cost. An opened or reconstituted vial cannot come back — nobody can verify what is in it or how it was kept.
What is this sold for?
In-vitro laboratory research, nothing else. Not for human or veterinary use; nothing on this page is medical advice, a dosing protocol or a recommendation.
On file.
| Form | COMBO |
| SKU | ZX-046 |
| Category | Immune & Cellular |
| Department | PEPTIDE |
What researchers reported.
Nothing reported on this vial yet. If you have worked with it, yours is the first.
From the research desk.
LongevityOral NAD+ itself: what the blood-level studies actually measured
The only randomised trial of an oral NAD+ product ran five days in 50 analysed adults and raised whole-blood intracellular NAD by 53% while plasma NAD did not move at all. That compartment split is the honest headline — and every clinical benefit in the field belongs to the precursors, not to the molecule.
AgingEpithalon and NAD+: what the aging research claims
The two are sold as a pair. PubMed holds no record that links them, the human supplementation record for NAD+ and its precursors is ten trials and 489 people, and the epithalon side of the story is cultured fetal fibroblasts and mice.
